Klotho Sciences Australia Pty Ltd.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1 Study to Assess the Safety and Effects of Single and Multiple Doses of KS101 in Healthy Volunteers	Alzheimer disease, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, brain disorder, central nervous system disorder, chronic renal failure syndrome, cognitive disorder, dementia, kidney disorder, kidney failure, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy, urinary system disorder	Not yet recruiting	Phase 1	2025-08-27		NCT07143331

Clinical trials